Luzindole, a melatonin receptor antagonist, suppresses experimental autoimmune encephalomyelitis

Pathobiology

Volumn 65, Issue 4, 1997, Pages 190-194

  Constantinescu, C S ^a   Hilliard, B ^a   Ventura, E ^a   Rostami, A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Autoimmunity; Demyelinating disease; Experimental autoimmune encephalomyelitis; Luzindole; Melatonin; Mouse; Receptor antagonist; Tcell

Indexed keywords

LUZINDOLE; MELATONIN; MELATONIN RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOSTIMULATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; TISSUE HOMOGENATE;

EID: 0030867140     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000164122     Document Type: Article

References (34)

1. Zamvil SS, Steinman L: The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 1990;8:579-621.
2. Haflcr DA, Weiner HL: MS: A CNA and systemic autoimmune disease. Immunol Today 1989;10:104-107.
3. O’Garra A. Murphy K: T-cell subsets in autoimmunity. Curr Opin Immunol 1993:5:880-886.
4. Blalock JH: A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol Rev 1989:69:1-32.
5. Reiter RJ: Pineal melatonin: Cell biology of its synthesis and of its physiological interactions. EndocrRev 1991;12:151-180.
6. Brzezinski A: Melatonin in humans. N Engl J Med 1997;336:186-195.
7. Maestroni JGM, Conti A: Melatonin and the immune system; in Touitou Y. Arcndt J. Pevct P (eds): Melatonin and the Pineal Gland. From Basic Science to Clinical Application. Amsterdam. Elsevier, 1993. pp 295-302.
8. Pioli C, Caroleo MO. Nistico G, Doria G: Melatonin increases antigen presentation and amplifies specific and nonspecific signals for T-cell proliferation, int J Immunopharmacol 1993;15:463-468.
9. Colombo LL, Chen G-J. Lopez MC, Watson RR: Melatonin induced increase in gamma-interferon production by murine splenocytes. Immunol Lett 1992:33:123-126.
10. Maestroni GJM. Conti A. Pierpaoli W: Role of pineal gland in immunity. I. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone. J Ncu-roimmunol 1986;13:19-30.
11. Hansson I. Holmdahi R. Mattsson R: The pineal hormone melatonin exaggerates development of collagen-induced arthritis in mice. J Neuroimmunol 1992;39:23-30.
12. Hansson I. Holmdahi R, Mattsson R: Constant darkness enhances autoimmunity to collagen-induced arthritis in DBA/1 mice. J Neuroimmunol 1990:27:79-84.
13. Hansson I. Holmdahi R, Mattsson R: Pinealec-tomy ameliorates collagen Il-induced arthritis in mice. Clin Exp Immunol 1993;92:432-436.
14. Schneider HA: Suppression of experimental allergic encephalomyelitis by microwaves from fluorescent lamps; in Alter M. Kurtzke JF (eds): The Epidemiology of Multiple Sclerosis. Springfield. CC Thomas. 1968. pp 144-171.
15. Dubocovich ML: Luzindole (N-0774): A novel melatonin receptor antagonist. J Pharmacol ExpThcr 1988;246:902-910.
16. Dubocovich ML, Mogilnicka E, Areso PM: An-tidepressant-like activity of the melatonin receptor antagonist, luzindole (N-0774). in the mouse behavioral despair test. Eur J Pharmacol 1990;182:313-325.
17. Constantincscu CS, Ventura E, Hilliard B, Ros-tami A: Effects of the angiotensin converting enzyme inhibitor captopril on experimental autoimmune encephalomyelitis. Immunophar-macol lmmunotoxicol 1995; 17:471-491.
18. Constantincscu CS: Melanin, melatonin, melanocyte-stimulating hormone and the susceptibility to autoimmune demyalination: A rationale for light therapy in multiple sclerosis. Med Hypotheses 1995;45:455-458.
19. Jemison LM, Williams SK, Lublin FD. Knob-ler RL. Komgold R: Interferon-gamma-inducible endothelial cell class 11 major histocompatibility complex expression correlates with strain- and site-specific susceptibility to experimental allergic encephalomyelitis. J Neuroim-munol 1993;47:15-22.
20. Baron JL, Madri JA. Ruddle NH, Hashim G. Janeway CA Jr: Surface expression of alpha 4 integrin by CD4 T cells is required for their entrv into brain parenchyma. J Exp Med 1993; 177:57-68.
21. Mason D, MacPhee I, Antoni F: The role of the neuroendocrine system in determining the genetic susceptibility to experimental allergic encephalomyelitis in the rat. Immunology 1990; 70:1-5.
22. luvone PM. Gan J: Melatonin receptor-mediated inhibition of cyclic AMP accumulation in chicken retinal cell cultures. J Neurochem 1994:63:118-124.
23. l25I]iodomelatonin by rat splenocytes: Characterization and its role on regulation of cyclic AMP production. J Neu-roimmunol 1995;57:171-178.
24. Han J, Thompson P, Beutler B: Dcxamctha-sonc and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 1990;172:391-394.
25. Chen D. Rothenberg EV: Interleukin-2 transcription factors as molecular targets of cAMP inhibition: Delayed inhibition kinetics and combinatorial transcriptional roles. J Exp Med 1994;179:931-942.
26. Rott O. Cash E. Fleischer B: Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1- but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats. Eur J Immunol 1993:23:1745-1751.
27. Genain CP. Roberts T. Davis RL, Nguyen MH, Uccelli A, Faulds D, Li Y, Hedgpeth J, Hauser SL: Prevention of autoimmune demye-lination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. Proc Natl Acad Sci USA 1995;92:3601-3605.
28. Nataf S. Louboutin JP. Chabanncs D, Feve JR, Muller JY: Pentoxifylline inhibits experimental allergic encephalomyelitis. Acta Neurol Scand 1993:88:97-99.
29. Sommer N, Loschmann PA, Northoff GH. Weller M, Steinbrccher A, Steinbach JP. Lich-tenfels R, Meyermann R, Ricthmullcr A, Fontana A, Dichgans J, Martin R: The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nature Med 1995;1:244-248.
30. Constantinescu CS, Hilliard B, Lavi E. Ventura E, Vcntatesh V, Rostami A: Suppression of experimental autoimmune neuritis by phosphodiesterase inhibitor pentoxiphylline. J Neurol Sci 1996;143:14-18.
31. Konakchieva R, Kyurkchiev S, Kehayov I, Taushanova P, Kanchev L: Selective effect of methoxyindolcs on the lymphocyte proliferation and melatonin binding to activated human lymphoid cells. J Neuroimmunol 1995;63: 125-132.
32. Zhang J. Markovic-Plese S. Lacet B, Raus J, Weiner HL. Hafier DA: Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 1994; 179:973-984.
33. Hafier DA, Fox DA. Manning ME. Schlossman SF. Reinherz EL, Weiner HL: In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. N Engl J Med 1985:312:1405-1411.
34. Constantincscu CS, Kamoun M, Dotti M, Far-ber RE, Galetta SL, Rostami A: A longitudinal study of the T cell activation marker CD26 in chronic progressive multiple sclerosis. J Neurol Sci 1995;130:178-182.